Author:
Zhang Tang ansu,Zhang Qian,Zhang Jun,Zhao Rong,Shi Rui,Wei Sitian,Liu Shuangge,Zhang Qi,Wang Hongbo
Abstract
Abstract
Background
Endometrial cancer (EC) is one of the worldwide gynecological malignancies. Endoplasmic reticulum (ER) stress is the cellular homeostasis disturbance that participates in cancer progression. However, the mechanisms of ER Stress on EC have not been fully elucidated.
Method
The ER Stress-related genes were obtained from Gene Set Enrichment Analysis (GSEA) and GeneCards, and the RNA-seq and clinical data were downloaded from The Cancer Genome Atlas (TCGA). The risk signature was constructed by the Cox regression and the least absolute shrinkage and selection operator (LASSO) analysis. The significance of the risk signature and clinical factors were tested by time-dependent receiver operating characteristic (ROC) curves, and the selected were to build a nomogram. The immunity correlation was particularly analyzed, including the related immune cells, pathways, and immune checkpoints. Functional enrichment, potential chemotherapies, and in vitro validation were also conducted.
Result
An ER Stress-based risk signature, consisting of TRIB3, CREB3L3, XBP1, and PPP1R15A was established. Patients were randomly divided into training and testing groups with 1:1 ratio for subsequent calculation and validation. Based on risk scores, high- and low-risk subgroups were classified, and low-risk subgroup demonstrated better prognosis. The Area Under Curve (AUC) demonstrated a reliable predictive capability of the risk signature. The majority of significantly different immune cells and pathways were enriched more in low-risk subgroup. Similarly, several typical immune checkpoints, expressed higher in low-risk subgroup. Patients of the two subgroups responded differently to chemotherapies.
Conclusion
We established an ER Stress-based risk signature that could effectively predict EC patients’ prognosis and their immune correlation.
Funder
International Science and technology cooperation project of Hubei Province
National Natural Science Foundation of China
Fundamental Research Funds for the Central Universities
Young Scientists Fund of the National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics
Reference49 articles.
1. Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N. Endometrial cancer. Lancet. 2022;399(10333):1412–28.
2. Passarello K, Kuria S, Villanueva V. Endometrial Cancer: an overview of Pathophysiology, Management, and Care. Semin Oncol Nurs. 2019;35(2):157–65.
3. Tung HJ, Huang HJ, Lai CH. Adjuvant and post-surgical treatment in endometrial cancer. Best Pract Res Clin Obstet Gynaecol. 2022;78:52–63.
4. Oakes SA, Papa FR. The role of endoplasmic reticulum stress in Human Pathology. Annu Rev Pathol. 2015;10:173–94.
5. Wang G, Yang ZQ, Zhang K. Endoplasmic reticulum stress response in cancer: molecular mechanism and therapeutic potential. Am J Transl Res. 2010;2(1):65–74.